We now have the clinical data package to support global submissions for retatrutide as a potential treatment for obesity, knee osteoarthritis pain, and obstructive sleep apnea. Key takeaways: Retatrutide met primary endpoints in the TRIUMPH-2 and TRIUMPH-3 trials, delivering substantial weight loss at 80 weeks
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
Gastrointestinal side effects represent the most common adverse reactions with GLP-1 receptor agonists, regardless of delivery method
Semaglutide and tirzepatide are both medications designed to help patients with type 2 diabetes manage their symptoms, but they are also highly effective for weight loss
Similar content being viewed by others Background In the United States, after cardiovascular disease and cancer, stroke is the third leading cause of death
What is the most attractive lip shape